The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPod Point Regulatory News (PODP)

Share Price Information for Pod Point (PODP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.00
Bid: 22.25
Ask: 22.75
Change: 0.00 (0.00%)
Spread: 0.50 (2.247%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 22.00
PODP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Updated 2023 Guidance

27 Jul 2023 16:11

RNS Number : 4677H
Pod Point Group Holdings PLC
27 July 2023
 

27 July 2023

Pod Point Group Holdings PLC

("Pod Point" or "the Group")

 

Updated 2023 guidance

 

Following the appointment of Andy Palmer as interim CEO on 6 July 2023, a detailed review of the Group's operations is being undertaken. While this work is ongoing, it has become clear that the outcome for the financial year ending 31 December 2023 will be materially different from the current guidance, with lower revenue and a larger adjusted EBITDA loss.

 

The market has remained volatile and uncertain, with particular weakness in the private BEV market. The Group has seen shortcomings in product offer, and delays in product and app launches that have impacted revenues. Some of our sales channels are also seeing slower conversion to revenue. These themes are expected to impact our performance in the second half.

 

Consequently, the Group is updating revenue guidance for 2023 to at least £60m. Adjusted EBITDA loss for 2023 is now expected to be no greater than £17m. The updated guidance includes the impact of lower revenues, and an expected £5m of costs related to transformation plan initiatives and growth investments identified as part of the ongoing strategy review and non-cash charges.

 

Our balance sheet remains in a strong position with net cash as at 30 June 2023 of £58.8m.

 

Alongside our interim results to be released on 31 July, we will provide further details on our transformation plan to improve operational and financial performance, the actions required to urgently address priorities and how Pod Point is positioning itself for long term growth.

 

 

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014.

 

The person responsible for arranging the release of this announcement on behalf of Pod Point is Anita Guernari, Company Secretary.

 

 

 

Enquiries: 

Pod Point Plc

Andy Palmer, interim Chief Executive Officer

David Wolffe, Chief Financial Officer

Phil Clark, Investor Relations phil.clark@pod-point.com

 

Numis (Joint Corporate Broker)

Jonathan Wilcox / Andrew Coates +44 (0)20 7260 1000

 

BofA Securities (Joint Corporate Broker)

Marcus Jackson / Mitchell Evans +44 (0)20 7628 1000

 

Media

Mark Burgess / Matt Low / Arthur Rogers (Teneo) +44 (0)20 7353 4200 PodPoint@teneo.com

 

 

 

About Pod Point Group Holdings plc

Pod Point was founded in 2009 by entrepreneur Erik Fairbairn. Driven by a belief that travel shouldn't damage the earth, Pod Point has over 210k smart communicating charge points on its network and is an official charge point supplier for major car brands.

Pod Point installs a broad range of products from smart domestic charge points to high power rapid chargers and load balancing systems. Pod Point works with a broad range of organisations and customers to offer home and commercial charging solutions with customers including major retailers, hotels, restaurants and leisure venues. 

Pod Point is admitted to trading on the London Stock Exchange under the ticker symbol "PODP."

For more information, visit https://pod-point.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBRVROKUBUAR
12
Date   Source Headline
30th Apr 202411:00 amRNSTotal Voting Rights
26th Apr 20242:29 pmRNSAnnual Report & Notice of AGM
19th Apr 202411:32 amRNSDirector/PDMR Shareholding
18th Apr 20247:00 amRNSPreliminary Results for FY2023
3rd Apr 20247:00 amRNSNotice of Results
3rd Apr 20247:00 amRNSChange of Joint Corporate Broker
2nd Apr 20249:00 amRNSEstablishment of Technology Committee
12th Mar 20249:00 amRNSChange of Registered Office
29th Feb 20248:33 amRNSTotal Voting Rights
20th Feb 20247:00 amRNSCEO Appointment & Directorate Change
20th Feb 20247:00 amRNSTrading Update
14th Feb 202411:24 amRNSBlock Listing Application
31st Jan 202410:45 amRNSTotal Voting Rights
10th Jan 202410:07 amRNSDirector Declaration
8th Dec 20238:47 amRNSBlock listing Interim Review
20th Nov 20233:13 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSTrading Update and Capital Markets Day
17th Aug 20232:29 pmRNSNotice of Capital Markets Day
10th Aug 20239:00 amRNSNew Contract Win
31st Jul 20237:00 amRNSHalf-year Report
28th Jul 20239:00 amRNSChange of Auditor
27th Jul 20234:11 pmRNSUpdated 2023 Guidance
6th Jul 20237:00 amRNSDirectorate Change
30th Jun 20239:00 amRNSNew Contract Win
28th Jun 20239:00 amRNSNew Contract Win
14th Jun 202310:10 amRNSResult of AGM
8th Jun 20239:14 amRNSBlock listing Interim Review
31st May 20239:29 amRNSDirector Declaration
25th May 20231:50 pmRNSDirector/PDMR Shareholding
28th Apr 20235:27 pmRNSAnnual Report & Notice of AGM
31st Mar 20233:47 pmRNSDirector/PDMR Shareholding
31st Mar 202310:24 amRNSTotal Voting Rights
21st Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20234:35 pmRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20231:37 pmRNSBlock Listing Application
17th Feb 20237:00 amRNSPreliminary Unaudited Results for FY2022
16th Feb 20239:58 amRNSBoard Committee Change
11th Jan 20237:00 amRNSCompany Secretary Change
3rd Jan 20237:00 amRNSTotal Voting Rights
28th Dec 202210:32 amRNSDirector/PDMR Shareholding
22nd Dec 20224:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
14th Dec 20227:00 amRNSExercise of Options and Issue of Shares
9th Dec 20227:00 amRNSBlock listing Interim Review
5th Dec 20227:00 amRNSCFO Appointment
21st Nov 20227:00 amRNSTrading Statement
7th Nov 20224:40 pmRNSSecond Price Monitoring Extn
7th Nov 20224:35 pmRNSPrice Monitoring Extension
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.